FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
Neurology Advisor1d
FDA Approves First New Non-Opioid Pain Pill in Decades
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
Experimental drug shows promise in reversing memory loss for early Alzheimer's patients
A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...
WLWT7d
FDA approves new pain drug Journavx as opioid alternative
Federal officials on Thursday approved ... brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids' addictive effects. Vertex’s ...
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
The Washington Post3d
FDA approves new, non-opioid painkiller Journavx
The Food and Drug Administration ... on the brain. Vertex said the wholesale cost would be $15.50 per 50-milligram pill, or $31 for a recommended starting dose. “Today’s approval is an ...
Yahoo7d
FDA approves first new non-opioid pain pill in 20 years—how it works
The FDA approved Journavx ... for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals before they reach the brain, avoiding opioid-related addiction risks.
WFMZ-TV7d
FDA Approves First New Non-Opioid Pain Pill in Decades
It's the first new non-opioid pain pill in ... reach the brain, avoiding opioid risks FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx ...